Top Hospital-Acquired Infections Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Hospital-Acquired Infections Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Hospital-Acquired Infections industry players.

Hospital-Acquired Infections Market Competitive Landscape

The market for hospital acquired infection control is highly competitive. Market participants are launching strategic activities such as customer acquisition, strategic collaborations, distribution network strengthening, and R&D. Key firms are also diversifying their portfolios and investing in new technologies to boost their market share. Steris, for example, expanded its offerings by acquiring Cantel Medical, a significant producer of infection prevention products and services, in June 2021.

Top Players in Hospital-Acquired Infections Market

  • STERIS plc (Ireland) 
  • Getinge AB (Sweden) 
  • 3M (USA) 
  • Ecolab Inc. (USA) 
  • Diversey Holdings, Ltd. (USA) 
  • Roche Holding AG (Switzerland) 
  • Abbott Laboratories (USA) 
  • bioMerieux S.A. (France) 
  • Thermo Fisher Scientific Inc. (USA) 
  • Becton, Dickinson and Company (BD) (USA) 
  • Pfizer Inc. (USA) 
  • Merck & Co., Inc. (USA) 
  • Novartis AG (Switzerland) 
  • GlaxoSmithKline plc (UK) 
  • Sanofi S.A. (France) 
  • Medtronic plc (Ireland) 
  • Cardinal Health (USA) 
  • Johnson & Johnson (USA)

Hospital-Acquired Infections Market Recent Development

  • In September 2021, Sodexo, a global leader in services that improve quality of life, announced that it has expanded its relationship with Ecolab in the United States for the control of hospital-acquired infections through the Protecta Plus program. This program was developed to lower infection risk in hospitals and healthcare facilities by employing Ecolab's Bioquell hydrogen peroxide vapour technology.
  • In June 2021, STERIS plc, a global provider of innovative healthcare and life science products and services, announced the completion of its acquisition of Cantel Medical, a global provider of infection control products and services to endoscopy, dental, dialysis, and life sciences customers.
REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Hospital-Acquired Infections Market size was valued at USD 30.4 billion in 2023 and is poised to grow from USD 30.86 billion in 2024 to USD 34.76 billion by 2032, growing at a CAGR of 1.5% during the forecast period (2025-2032).

The market for hospital acquired infection control is highly competitive. Market participants are launching strategic activities such as customer acquisition, strategic collaborations, distribution network strengthening, and R&D. Key firms are also diversifying their portfolios and investing in new technologies to boost their market share. Steris, for example, expanded its offerings by acquiring Cantel Medical, a significant producer of infection prevention products and services, in June 2021. 'STERIS plc (Ireland) ', 'Getinge AB (Sweden) ', '3M (USA) ', 'Ecolab Inc. (USA) ', 'Diversey Holdings, Ltd. (USA) ', 'Roche Holding AG (Switzerland) ', 'Abbott Laboratories (USA) ', 'bioMerieux S.A. (France) ', 'Thermo Fisher Scientific Inc. (USA) ', 'Becton, Dickinson and Company (BD) (USA) ', 'Pfizer Inc. (USA) ', 'Merck & Co., Inc. (USA) ', 'Novartis AG (Switzerland) ', 'GlaxoSmithKline plc (UK) ', 'Sanofi S.A. (France) ', 'Medtronic plc (Ireland) ', 'Cardinal Health (USA) ', 'Johnson & Johnson (USA)'

The number of surgical procedures performed worldwide has increased significantly throughout the years. Every year, around 235 million major surgical procedures are conducted worldwide, according to the WHO (2019). This is due to the rising frequency of obesity and other lifestyle disorders, an aging population, and an increase in spine injuries and sports-related injuries. As the number of surgical procedures performed grows, so does the demand for various surgical equipment and medical gadgets. Because of the demonstrated benefits of sterilized items and increased awareness about their usefulness in healthcare settings, this is projected to stimulate demand for hospital acquired infection services.

The rise in the prevalence of chronic diseases such as gastroesophageal reflux disease (GERD), IBD, peptic ulcer disease, crohn's disease, diabetes, hypertension, cardiovascular disorders, cancer, and others due to environmental pollution, smoking, unhealthy lifestyles, poor nutrition and diet, and high intake of carcinogenic substances will drive the market for hospital acquired infection control devices. According to the International Diabetes Federation's Diabetes Atlas 10th edition report 2021, 537 million individuals (20-79 years) worldwide are diabetic. This figure is expected to climb to 643 million by 2030 and 783 million by 2045. The increased frequency of chronic disease will increase the number of surgical procedures. As the number of procedures increases, so will the risk of hospital-acquired infections. Infection transmission can be stopped by using adequate sterilization and disinfection procedures. As a result of the increased incidence of chronic illnesses, the rising number of surgical operations may raise the prevalence of hospital acquired infections, thus boosting the demand for hospital acquired infection control products. Thus, the aforementioned aspect is expected to boost the overall market growth of hospital acquired infection control products over the forecast period.

North America dominated the market in 2021, accounting for more than 34.0% of total sales. The substantial share can be due to the presence of key players, activities implemented by them in the public and commercial sectors, and increased awareness of HAIs in this region. For example, in December 2020, Ecolab, headquartered in the United States, acquired vanBaerle Hygiene AG in Switzerland. This expanded Ecolab's product line and service capabilities to include a comprehensive spectrum of cleaning, disinfection, and hygiene solutions.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Hospital-Acquired Infection Control Market
Buy Now GET FREE SAMPLE
Infection Control Market
Buy Now GET FREE SAMPLE
Infectious Disease Diagnostics Market
Buy Now GET FREE SAMPLE
Antibiotics Market
Buy Now GET FREE SAMPLE
Hospital Services Market
Buy Now GET FREE SAMPLE
Infectious Disease Therapeutics Market
Buy Now GET FREE SAMPLE
Hospital Beds Market
Buy Now GET FREE SAMPLE
Bacteriophage Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Hospital-Acquired Infections Market
Hospital-Acquired Infections Market

Report ID: SQMIG35I2254

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE